[ad_1]
Data on vaccine development has been passed on to the pharmaceutical health management products regulatory agency
Minister of Health “Free, available to those in need”
The UK government has started the approval process for a new coronavirus infection vaccine (Corona 19) developed by Pfizer and Bioentech.
According to Reuters and Sky News on the 20th (local time), British Health Minister Matt Hancock made this announcement through a press conference in response to Corona 19.
“The first step towards a vaccine license in the UK is for the government to make a formal application for compliance assessment to the independent regulatory body, the Drug and Health Care Products Regulatory Authority (MHRA),” said Hancock. I delivered it. “
In this regard, he explained that the company has already started providing data on vaccine development to the MHRA.
“This is a very important step in responding to the pandemic,” Hancock said. “If the vaccine is approved, it will certainly be freely available throughout the UK through the National Health Service (NHS).”
He stressed that the vaccine would be made available as needed, not the individual’s ability to pay.
Minister Hancock said that once the vaccine is approved, vaccination will begin in December and will be carried out on a large scale next year.
“We are going in the right direction, but we still have a long way to go,” he said. “The coronavirus still remains a very big risk.”
Pfizer and Bioentech have already applied for approval for the use of emergency vaccines from the US Food and Drug Administration (FDA) before the UK.
Pfizer is the first to apply for approval for emergency use of the Corona 19 vaccine from the FDA.
/ news yunhap
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
Source link
